Status:
RECRUITING
Development of a New Canadian Endourology Group Stent Symptom Score
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborating Sponsors:
Université de Montréal
University of British Columbia
Conditions:
Urologic Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Placement of a ureteral stent is a common urological intervention. For decades there was no valid measures available to assess quality of life issues in patients with ureteral stents, which has hamper...
Detailed Description
This research project is conducted in 3 phases, phase 1 and 2 have been completed and phase 3 is under preparation and will be submitted to the Research Ethics Board soon. Phase 1: Prioritizing Domai...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Patient with ureteral stent
- Ability to communicate in English
Exclusion
- Inability to provide an informed consent due to physical or mental inability
- Active malignancy
- Obstruction
- Long-term stent (\>2 weeks)
Key Trial Info
Start Date :
May 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 15 2025
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04909541
Start Date
May 15 2022
End Date
September 15 2025
Last Update
June 7 2024
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Los Angeles
Los Angeles, California, United States, 90095
2
Cleveland Clinic - University of Toronto.
Mayfield Heights, Ohio, United States, 44124
3
Alberta University - Northern Alberta Urology Centre
Edmonton, Alberta, Canada, T6G 1Z1
4
Vancouver General Hospital
Vancouver, British Columbia, Canada, V6X 1Z9